Grudzińska, E.; Durajczyk, M.; Grudziński, M.; Marchewka, Ł.; Modrzejewska, M. Usefulness Assessment of Automated Strabismus Angle Measurements Using Innovative Strabiscan Device. J. Clin. Med.2024, 13, 1067.
Grudzińska, E.; Durajczyk, M.; Grudziński, M.; Marchewka, Ł.; Modrzejewska, M. Usefulness Assessment of Automated Strabismus Angle Measurements Using Innovative Strabiscan Device. J. Clin. Med. 2024, 13, 1067.
Grudzińska, E.; Durajczyk, M.; Grudziński, M.; Marchewka, Ł.; Modrzejewska, M. Usefulness Assessment of Automated Strabismus Angle Measurements Using Innovative Strabiscan Device. J. Clin. Med.2024, 13, 1067.
Grudzińska, E.; Durajczyk, M.; Grudziński, M.; Marchewka, Ł.; Modrzejewska, M. Usefulness Assessment of Automated Strabismus Angle Measurements Using Innovative Strabiscan Device. J. Clin. Med. 2024, 13, 1067.
Abstract
Background: The variability of the obtained results of manual tests assessing the angle of strabismus depends on the experience, skills, and training of the examiner. The authors hope that the new measuring device will provide a more sensitive and repeatable method for detecting small strabismus angles compared to the gold standard – PCT. The purpose of this article is to present an innovative strabismus angle demonstration device, called Strabiscan, to present automated measurements of eye deviation, and to compare the obtained results of these measurements to the traditional manual method. Methods: In patients with the manifest strabismic disease (n = 30) and a group of healthy subjects (n = 30), a detailed history was taken and routine ophthalmologic examinations were performed, including best-corrected distance visual acuity, assessment of refractive error using an autorefractometer after cycloplegia, biomicroscopic evaluation of the anterior segment of the eye, and evaluation of the eye fundus by indirect ophthalmoscopy. Subsequently, each patient and healthy subjects were subjected to a prismatic cover-uncover test using a manual method, and then the presence of strabismus was detected and its angle assessed using demonstration Strabiscan device. Results: In the control group, using the Strabiscan demonstration device, small-angle latent strabismus ≤3DP was diagnosed in 83% of patients, and >3DP in 13%. In contrast, using the prismatic cover-uncover test, latent strabismus ≤3DP was diagnosed in only 13% of patients, and latent strabismus with an angle >3DP in 13% of patients. No statistically significant differences were noted in the measurements of strabismus angles made by the different methods. Conclusions: The Strabiscan demonstration device allows quick and accurate assessment of the strabismus angle. Compared to the prismatic cover-uncover test, it has a higher sensitivity for detecting low-angle latent strabismus. Measurements with the Strabiscan do not require the presence of additional co-assistants for the test.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
